Connection
Kurt Stenmark to Drug Repositioning
This is a "connection" page, showing publications Kurt Stenmark has written about Drug Repositioning.
|
|
Connection Strength |
|
 |
|
 |
|
0.153 |
|
|
|
-
Rashid J, Alobaida A, Al-Hilal TA, Hammouda S, McMurtry IF, Nozik-Grayck E, Stenmark KR, Ahsan F. Repurposing rosiglitazone, a PPAR-? agonist and oral antidiabetic, as an inhaled formulation, for the treatment of PAH. J Control Release. 2018 06 28; 280:113-123.
Score: 0.153